Borealis Biosciences Emerges from Stealth with $150M Series A Financing
Key Highlights Borealis Biosciences launched with $150 million in Series A financing from Versant Ventures and Novartis. Strategic research…
FDA Clears AISAP CARDIO: AI-Powered Ultrasound Revolutionizes Point-of-Care Diagnostics
Key Highlights AISAP CARDIO receives FDA 510(k) clearance for AI-powered cardiac diagnostics. Integrates 4 CADx modules and 8 key measurements into a comprehensive software platform.…
Michael Dougherty Resigns as CFO of bioAffinity Technologies, Inc.
Key Highlights Michael Dougherty resigns as CFO to join the energy industry in the Pacific Northwest. J. Michael Edwards…
PureTech Health Appoints Michele Holcomb, PhD, to Board of Directors
Key Highlights Michele Holcomb, PhD, joins PureTech Health board as an independent non-executive director, effective September 23, 2024. Dr. Holcomb…
BioAge Labs Appoints Jean-Pierre Garnier as Chair of Board of Directors
Key Highlights BioAge Labs appoints Jean-Pierre Garnier, PhD, as Chair of the Board of Directors. Garnier brings extensive leadership experience from…
ReAlta Life Sciences Appoints David Marek as CEO and Paolo Martini, Ph.D., as Chief R&D Officer
Key Highlights David Marek appointed as Chief Executive Officer of ReAlta Life Sciences. Paolo Martini, Ph.D. named Chief Research and Development Officer. ReAlta…
Forge Health Secures Strategic Growth Investment from MFO Ventures
Key Highlights Forge Health receives strategic growth investment from MFO Ventures. Funds to expand nationwide virtual care, psycho-oncology services, and…
NRC Health Unveils AI-Enabled Product Suite, Acquisition, and Partnership at HUB24
Key Highlights NRC Health introduces next-gen AI products powered by Huey™, the first AI engine for healthcare. Acquires…
Retension Pharmaceuticals Secures $10.4M Series A to Advance Phase 2 Hypertension Study
Key Highlights $10.4 million Series A funding secured to advance RTN-001 for hypertension treatment. RTN-001 targets patients with uncontrolled…
Asensus Surgical Completes Merger with KARL STORZ Group
Key Highlights Asensus Surgical merges with KARL STORZ Group, becoming a subsidiary. Merger completed with stockholder approval; $0.35…